`
`IPR2018-00608
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`AMNEAL PHARMACEUTICALS LLC AND
`AMNEAL PHARMACEUTICALS OF NEW YORK, LLC,
`Petitioners,
`
`v.
`
`ALMIRALL, LLC,
`Patent Owner.
`
`Case IPR2018-00608
`Patent 9,161,926
`
`
`
`
`
`
`
`PATENT OWNER ALMIRALL, LLC’s
`MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent Owner’s Mandatory Notices Under 37 C.F.R. § 42.81
`
`IPR2018-00608
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Almirall, LLC (“Almirall”)
`
`submits the following Mandatory Notices. These notices are submitted within 21
`
`days of the assignment of U.S. Patent No. 9,161,926 to Almirall, LLC (Exhibit
`
`2001), and reflect lead and backup counsel appointed by Almirall:
`
`A. Real Party-In-Interest Under 37 C.F.R. § 42.8(b)(1)
`
`The real party-in-interest is Almirall, LLC, a Pennsylvania limited liability
`
`company. Almirall, LLC is an indirect subsidiary of Almirall, S.A., a publicly-listed
`
`company.
`
`B. Related Matters Under 37 C.F.R. § 42.8(b)(2)
`
`Almirall is not presently aware of any other proceedings involving U.S. Patent
`
`No. 9,161,926. The ’926 patent is the parent of continuation U.S. Patent No.
`
`9,517,219, which is the subject of Allergan, Inc. v. Taro Pharmaceutical Industries
`
`Ltd. and Taro Pharmaceuticals, Inc., Civil Action No. 17-663 (VAC) (SRF)
`
`(Consol.) (D.Del.), filed June 1, 2017.
`
`C.
`
`Lead and Back-Up Counsel Under 37 C.R.F. § 42.8(b)(3)
`
`Almirall designates the following Lead Counsel:
`
`James Trainor (Reg. No. 52,297)
`FENWICK & WEST LLP
`902 Broadway, Suite 14
`New York, NY 10010-6035
`Tel:
`212.921.2001
`Fax:
`
`650.938.5200
`Email:
`jtrainor@fenwick.com
`
`
`
`
`
`
`
`
`
`Patent Owner’s Mandatory Notices Under 37 C.F.R. § 42.81
`
`IPR2018-00608
`
`
`
`Almirall designates the following as Back-Up Counsel under 37 C.F.R. ¶
`
`42.10(a):
`
`Ewa M. Davison (Reg. No. 74,498)
`FENWICK & WEST LLP
`1191 Second Avenue, 10th Floor
`Seattle, WA 98101
`Tel:
`206.389.4510
`Fax:
`
`206.389.4511
`Email:
`edavison@fenwick.com
`
`Elizabeth B. Hagan (pro hac vice to be filed)
`FENWICK & WEST LLP
`1191 Second Avenue, 10th Floor
`Seattle, WA 98101
`Tel:
`206.389.4510
`Fax:
`
`206.389.4511
`Email:
`ehagan@fenwick.com
`
`D.
`
`Service Information Under 37 C.F.R. § 42.8(b)(4)
`
`Almirall may be served through its counsel, Fenwick & West LLP, at the
`
`above-indicated postal and email addresses.
`
`E.
`
`Power of Attorney
`
`A Power of Attorney to transact all business in the United States Patent and
`
`Trademark Office in connection with the above-referenced Inter Partes Review
`
`from Patent Owner Almirall, LLC to the above-designated counsel at Fenwick &
`
`West LLP is being filed concurrently with these Mandatory Notices. The Power of
`
`Attorney is accompanied by a Statement Under 37 C.F.R. § 3.73(c), executed by the
`
`Patent Owner.
`
`
`
`
`
`
`
`
`
`Patent Owner’s Mandatory Notices Under 37 C.F.R. § 42.81
`
`IPR2018-00608
`
`
`Dated: October 29, 2018
`
`
`Respectfully submitted,
`
`FENWICK & WEST LLP
`
`By: /James Trainor/
`James Trainor (Reg. No. 52,297)
`
`
`
`Attorneys for Patent Owner
`Almirall, LLC
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent Owner’s Mandatory Notices Under 37 C.F.R. § 42.81
`
`IPR2018-00608
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that the foregoing Patent
`
`Owner’s Revocation of Power of Attorney and New Power of Attorney Pursuant to
`
`37 C.F.R. § 42.10(B) was served by electronic mail on the following counsel of
`
`record for petitioner:
`
`
`
`Dated: October 29, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`Dennies Varughese (dvarughe-PTAB@skgf.com)
`Adam C. LaRock (alarock-PTAB@skgf.com)
`PTAB@skgf.com
`Sterne, Kessler, Goldstein & Fox
`1100 New York Avenue, NW
`
`Respectfully submitted,
`
`FENWICK & WEST LLP
`
`By: /James Trainor/
`James Trainor (Reg. No. 52,297)
`
`
`
`Attorneys for Patent Owner
`Almirall, LLC
`
`
`
`
`
`
`
`